Huasky Medical Holding Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Huasky Medical Holding Ltd - overview
Established
2005
Location
Beijing, -, China
Primary Industry
Outsourcing
About
Established in 2005 and based in Beijing, China, Huasky Medical Holding Ltd operates as a clinical CRO company that provides SMO, third-party audit, CRO, pharmacovigilance, drug registration and medical device services. The company is a subsidiary of Yangpu Star Pharmaceutical Co. ,Ltd. Xinmin Dai, the founder and chairman of the company, is vice chairman of the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce.
Cailian Kang, the CEO and CMO of the company, graduated from Tongji Medical University and is the former CDE senior reviewer. In July 2021, it raised USD 50 million in series C funding from OrbiMed Advisors and SPDB International, and Springs Capital, Zhongyuan Capital, Xiading Capital, and Xinling Capital. In February 2023, Anshun City Government became the strategic partner of the company. The company's business is divided into six series, which include SMO, third-party audit, CRO, pharmacovigilance, drug registration and medical device.
It has many clients, such as Sinopharm, Sailing and Tennor Therapeutics.
Current Investors
OrbiMed Advisors, Springs Capital, Zhongyuan Capital
Primary Industry
Outsourcing
Sub Industries
Consulting Services, BPO Services
Website
www.huasky-cro.com
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.